Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention DOI Creative Commons
Rui Yang,

Jin-Ling Wan,

Chen-Qi Pi

и другие.

Frontiers in Psychiatry, Год журнала: 2024, Номер 15

Опубликована: Июль 15, 2024

Examine the alterations in antipsychotic concentrations following coronavirus disease-2019 (COVID-19) infection among hospitalized patients with mental disorders and conduct an analysis of factors influencing these changes.

Язык: Английский

Remote mental health care interventions during the COVID-19 pandemic: An umbrella review DOI Creative Commons
Anke B. Witteveen, Susanne Y. Young, Pim Cuijpers

и другие.

Behaviour Research and Therapy, Год журнала: 2022, Номер 159, С. 104226 - 104226

Опубликована: Ноя. 11, 2022

Mitigating the COVID-19 related disruptions in mental health care services is crucial a time of increased disorders. Numerous reviews have been conducted on process implementing technology-based during pandemic. The research question this umbrella review was to examine what impact access and delivery how changed A systematic search for meta-analyses up August 12, 2022, 38 were identified. Main reduced outpatient admissions earlier discharge from inpatient care. In response, synchronous telemental tools such as videoconferencing used provide remote similar pre-COVID care, lesser extent asynchronous virtual apps. Implementation facilitated by time-efficiency flexibility pandemic but there lack accessibility specific vulnerable populations. barriers among practitioners patients use digital poor technological literacy, particularly when preexisting inequalities existed, beliefs about therapeutic alliance case severe Absence organizational support implementation interventions due inadequate IT infrastructure, funding, well privacy safety, challenged COVID-19. Reviews low moderate quality, covered heterogeneously designed primary studies lacked findings low- middle-income countries. These gaps evidence prevalent early This shows that pandemic, institutions mainly tools, degree enable continued patients. these identified, call further improvements. addition, more high quality into comparative effectiveness working mechanisms may improve scalability general future infectious disease outbreaks.

Язык: Английский

Процитировано

58

Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review DOI Creative Commons
Federico Bertolini, Anke B. Witteveen, Susanne Y. Young

и другие.

BMC Psychiatry, Год журнала: 2023, Номер 23(1)

Опубликована: Март 20, 2023

Abstract Introduction The COVID-19 pandemic has posed a serious health risk, especially in vulnerable populations. Even before the pandemic, people with mental disorders had worse physical outcomes compared to general population. This umbrella review investigated whether having pre-pandemic disorder was associated due pandemic. Methods Following pre-registered protocol available on Open Science Framework platform, we searched Ovid MEDLINE All, Embase (Ovid), PsycINFO CINAHL, and Web of up 6th October 2021 for systematic reviews impact pre-existing disorders. following were considered: risk contracting SARS-CoV-2 infection, severe illness, related mortality long-term symptoms after COVID-19. For meta-analyses, considered adjusted odds ratio (OR) as effect size measure. Screening, data extraction quality assessment AMSTAR 2 tool have been done parallel duplicate. Results We included five meta-analyses four narrative reviews. reported that any an increased infection (OR: 1.71, 95% CI 1.09–2.69), illness course (OR from 1.32 1.77, 95%CI between 1.19–1.46 1.29–2.42, respectively) 1.38 1.52, 1.15–1.65 1.20–1.93, People anxiety SAR-CoV-2 but not mortality. mood schizophrenia spectrum without evidence illness. Narrative consistent findings meta-analyses. Discussion conclusions As population, there is strong showing suffered may therefore be group similar underlying conditions. Factors likely involved include living accommodations barriers social distancing, cardiovascular comorbidities, psychotropic medications difficulties accessing high-intensity medical care.

Язык: Английский

Процитировано

26

Mental Health Impact of Early Stages of the COVID-19 Pandemic on Individuals with Pre-Existing Mental Disorders: A Systematic Review of Longitudinal Research DOI Open Access
Angela Kunzler, Saskia Lindner,

Nikolaus Röthke

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2023, Номер 20(2), С. 948 - 948

Опубликована: Янв. 4, 2023

In view of disease-related threats, containment measures, and disrupted healthcare, individuals with pre-existing mental illness might be vulnerable to adverse effects the COVID-19 pandemic. Previous reviews indicated increased distress, limited information on peri-pandemic changes. this systematic review, we aimed identify longitudinal research investigating pre- and/or changes health in patients, focusing early phase considering specific diagnoses. PsycINFO, Web Science, WHO Global literature coronavirus disease database, Cochrane Study Register weresearched through 31 May 2021. Studies were synthesized using vote counting based effect direction. We included 40 studies mostly from Western, high-income countries. Findings heterogeneous, improving deteriorating observed compared pre-pandemic data, partly depending underlying For changes, evidence was limited, some suggestion recovery distress. quality heterogeneous; only few investigated potential moderators (e.g., chronicity illness). Mental people conditions are heterogeneous within across diagnoses for comparisons. To improve services amid future global crises, forthcoming should understand medium- long-term effects, controlling measures.

Язык: Английский

Процитировано

23

Trends and prevalence of suicide 2017–2021 and its association with COVID-19: Interrupted time series analysis of a national sample of college students in the United States DOI

Yusen Zhai,

Xue Du

Psychiatry Research, Год журнала: 2022, Номер 316, С. 114796 - 114796

Опубликована: Авг. 14, 2022

Язык: Английский

Процитировано

36

The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials DOI Open Access
Giovanni Croatto, Davy Vancampfort, Alessandro Miola

и другие.

Molecular Psychiatry, Год журнала: 2022, Номер 28(1), С. 369 - 390

Опубликована: Сен. 22, 2022

Язык: Английский

Процитировано

31

Suicidality in clinically stable bipolar disorder and schizophrenia patients during the COVID-19 pandemic DOI Creative Commons
Yuchen Li, Wei Bai, Hong Cai

и другие.

Translational Psychiatry, Год журнала: 2022, Номер 12(1)

Опубликована: Июль 29, 2022

Abstract The coronavirus disease 2019 (COVID-19) pandemic has a disproportionate impact on vulnerable subpopulations, including those with severe mental illness (SMI). This study examined the one-year prevalence of suicidal ideation (SI), suicide plans (SP), and attempts (SA) in bipolar disorder (BD) schizophrenia (SCZ) patients during pandemic. Prevalence rates were compared between two disorders associated factors examined. A survey was conducted six tertiary psychiatric hospitals units. People diagnosis BD or SCZ invited to participate. SI, SP, SA (suicidality for short) assessed using binary logistical regression. 1-year SP 58.3%, (95% CI: 54.1–62.6%), 38.4% 34.3–42.6%) 38.6% 34.5–42.8%), respectively, which higher than corresponding figures (SI: 33.2%, 95% 28.6–37.8%; SP: 16.8%, 13.2–20.5%; SA: 19.4%, 15.5–23.3%). Patients younger age, experience cyberbullying, history among family friends, fatigue physical pain score, inpatient status, depressive symptoms more likely have suicidality. COVID-19 increased risk suicidality, particularly patients. It is importance regularly screen suicidality even if they are clinically stable.

Язык: Английский

Процитировано

24

Harmonizing early intervention strategies: scoping review of clinical high risk for psychosis and borderline personality disorder DOI Creative Commons
Gabriele Lo Buglio, Tommaso Boldrini, Andrea Polari

и другие.

Frontiers in Psychology, Год журнала: 2024, Номер 15

Опубликована: Июнь 20, 2024

Aims To map studies assessing both clinical high risk for psychosis (CHR-P) and borderline personality disorder (BPD) in samples, focusing on clinical/research/preventive paradigms proposing informed research recommendations. Methods We conducted a PRISMA-ScR/JBI-compliant scoping review (protocol: https://osf.io/8mz7a ) of primary (cross-sectional/longitudinal designs) using valid measures/criteria to assess CHR-P BPD (threshold/subthreshold) reporting CHR-P/psychotic symptoms disorder(s) the title/abstract/keywords, identified Web Science/PubMed/(EBSCO)PsycINFO until 23/08/2023. Results 33 were included categorized into four themes reflecting their respective paradigm: (i) as comorbidity youth ( k = 20), emphasizing early detection intervention psychosis; (ii) attenuated syndrome (APS) among inpatients 2), with focus hospitalized adolescents/young adults admitted non-psychotic mental disorders; (iii) mixed samples 7), including descriptions services referral pathways; (iv) transdiagnostic approaches 4) highlighting “clinical at state” (CHARMS) criteria identify pluripotent state severe disorders. Conclusion The reveals diverse care BPD, no unified treatment strategies. Recommendations future should on: exploring pathways across clinics promote timely intervention; enhancing strategies innovative settings such emergency departments; improving health literacy facilitate help-seeking behaviors; analysing comorbid disorders complex systems better understand target psychopathology; (v) investigating prospective BPD; (vi) developing interventions; (vii) engaging lived experience gain insight subjective experience; (viii) understanding caregiver burden craft family-focused (ix) expanding underrepresented regions Africa Asia, and; (x) evaluating cost-effectiveness interventions determine scalability different countries. Systematic Review Registration .

Язык: Английский

Процитировано

5

The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach DOI Creative Commons
Christoph U. Correll, Craig Chepke,

Paul Gionfriddo

и другие.

BMC Psychiatry, Год журнала: 2022, Номер 22(1)

Опубликована: Янв. 10, 2022

Abstract Background Long-acting injectable antipsychotics (LAIs) are an essential maintenance treatment option for individuals with schizophrenia or bipolar I disorder (BP-I). This report summarizes a roundtable discussion on the impact of COVID-19 mental healthcare landscape and use LAIs BP-I. Methods Ten experts stakeholders from diverse fields participated in pandemic, challenges, gaps BP-I, informed by literature search. Results Individuals BP-I at increased risk infection mortality after diagnosis. LAI prescriptions decreased early driven decrease face-to-face consultations. Mental services adapting telehealth home-based treatment. Clinical workflows to provide consistent, in-person include screening exposure infection, minimizing contact, ensuring mask-wearing staff. The importance continued visits needs be discussed so that staff can share information patients, their caregivers, families. A fully integrated, collaborative-care model is most important aspect care during pandemic. Conclusions pandemic has highlighted integrated ensure regular, routine contact access prescribed treatments

Язык: Английский

Процитировано

16

The Relationship between Mental Disorders and the COVID-19 Pandemic—Course, Risk Factors, and Potential Consequences DOI Open Access

Agnieszka Markiewicz-Gospodarek,

Aleksandra Górska,

Renata Markiewicz

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2022, Номер 19(15), С. 9573 - 9573

Опубликована: Авг. 4, 2022

In this review the authors discuss that COVID-19 has already had a direct impact on physical health of many people and it appears to have put at risk mental large populations. review, we also relationship between disorders SARS-CoV-2 infection. We convey disorders’ factors more serious disorder consequences COVID-19. People with could be susceptible emotional responses brought by epidemic. The pandemic may adversely influence patients diagnosed disorders. For aim dealing better psychological problems afflicted pandemic, new procedures are required.

Язык: Английский

Процитировано

16

Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason DOI Creative Commons
Pierre A. Geoffroy, Valentina Decio, Philippe Pirard

и другие.

Journal of Affective Disorders, Год журнала: 2024, Номер 350, С. 332 - 339

Опубликована: Янв. 21, 2024

Although hospitalisation for COVID-19 is associated with a higher post-discharge risk of mood disorders, including major depressive disorder (MDD) and bipolar (BD), this has not been compared to that following reason other than COVID-19.

Язык: Английский

Процитировано

3